Hetero launches generic breast cancer treatment drug in India

Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country.

View in App Tax Saving Tips
Agencies
The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.
New Delhi: Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the company said.

The product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs), it added.

The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.


At present, the company has 36 manufacturing facilities worldwide and has presence in over 126 countries.
READ MORE
View in App
Smart ways to save Tax
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

ET Business Listings
Generate Enquiries for your Business by Listing on Economictimes.com

More from our Partners

Loading next story
Text Size:AAA

ET Sections

View Full Site »
Download App

More from our network

save image

Success
This article has been saved

*